Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

1,296 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed

NCT00968357

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • AGMG Clinical Research Anaheim, California, United States
  • Impact Clinical Trials Los Angeles, California, United States
  • A Professional Corporation Palm Springs, California, United States
  • Arapahoe Gastroenterology Littleton, Colorado, United States
View all 16 locations
View Trial Details
Completed

SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C

NCT00110799

Conditions
Blood Platelet Disorders, Blood-Borne Infections, Chronic Disease, +20 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site St Louis, Missouri, United States
View all 30 locations
View Trial Details
Completed

Treatment of Recurrent Hepatitis C After Liver Transplantation

NCT00151580

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Service d'Hépatologie - Hôpital Jean Minjoz Besançon, France
  • Service de Chirurgie Digestive - Groupe Hospitalier Pellerin-Tripode Bordeaux, France
  • Service d'Hépatogastroentérologie - Hôpital Beaujon Clichy, France
  • Service d'Hépatologie et Gastroentérologie - Hôpital Henri Mondor Créteil, France
View all 16 locations
View Trial Details
Completed

The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections

NCT00001035

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +21 more
Locations
  • USC CRS Los Angeles, California, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
  • NY Univ. HIV/AIDS CRS New York, United States
View Trial Details
Completed

Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Responders

NCT01051921

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Scripps Clinic La Jolla, California, United States
  • VA Medical Center, San Diego San Diego, California, United States
  • University of Colorado Health Science Center Denver, Colorado, United States
  • South Denver Gastroenterology Englewood, Colorado, United States
View all 15 locations
View Trial Details
Completed

CTS-1027 in Interferon-Naive Hepatitis C Patients

NCT00925990

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Medical Associates Research Group San Diego, California, United States
  • Kaiser Permanante San Diego, California, United States
  • VA Medical Center, San Diego San Diego, California, United States
View all 21 locations
View Trial Details

Related conditions